DNA-Unresponsive Platinum(II) Complex Induces ERS-Mediated Mitophagy in Cancer Cells

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Mitophagy is a crucial cellular process for removing damaged mitochondria.
• Monofunctional platinum(II) complexes show promise as anticancer agents, potentially overcoming cisplatin resistance.
• The precise mechanism of action for these platinum complexes remains largely unknown.

Purpose of the Study:

• To elucidate the mechanism by which the monofunctional platinum(II) complex, Mono-Pt, induces cancer cell death.
• To investigate the role of mitophagy and endoplasmic reticulum stress in Mono-Pt's anticancer activity.
• To determine if Mono-Pt's efficacy is linked to DNA binding, unlike traditional platinum drugs.

Main Methods:

• Treatment of cancer cells with Mono-Pt.
• Assessment of mitochondrial integrity and function (membrane potential, ROS, ATP levels, mtDNA transcription).
• Evaluation of endoplasmic reticulum stress (ERS) markers and the unfolded protein response (UPR).
• Analysis of Mono-Pt's interaction with nuclear DNA.

Main Results:

• Mono-Pt triggers cancer cell death through a mitophagy pathway.
• The mechanism involves inducing endoplasmic reticulum stress (ERS) and activating the unfolded protein response (UPR).
• Mono-Pt disrupts mitochondrial structure and function, leading to mitophagy, without binding to nuclear DNA.
• Significant antiproliferative activity was observed, defying classical platinum drug structure-activity relationships.

Conclusions:

• Mono-Pt utilizes an ERS-mediated mitophagy pathway for anticancer effects.
• This mechanism represents a novel mode of action for platinum-based anticancer drugs, distinct from DNA binding.
• The findings broaden the scope for developing new platinum anticancer agents with potentially reduced side effects and improved efficacy.